Composition of notoginsen triterpenes and tanshinone IIA sodium sulfonate

Abstract

The invention belongs to the field of pharmacy, wherein a composition including the active constituents of notoginsen triterpenes and tanshinone IIA or pharmaceutically acceptable salts is disclosed, the invention also discloses the preparation containing the pharmaceutical composition and its preparing process, the composition can be made into clinically and pharmaceutically acceptable dose forms including oral liquids or injections.

Description

[technical field] [0001] The invention belongs to the technical field of medicine, and relates to a composition consisting of Panax notoginseng saponins and Tanshinone II containing medicinal components. A A pharmaceutical composition or a pharmaceutically acceptable salt thereof, a preparation containing the pharmaceutical composition and a preparation method thereof. [Background technique] [0002] Cardiovascular and cerebrovascular diseases such as stroke, coronary heart disease, and angina pectoris are one of the main causes of human death. According to the report of the World Health Organization, the mortality rate of cardiovascular diseases in the world accounted for 29% of the total mortality rate in 1990, ranking second. In 1994 The number of deaths worldwide is 52.2 million in 2000, of which 15.3 million died of cardiovascular diseases, while in 1999 the number of deaths from cardiovascular diseases in the world was 16.97 million, accounting for 30.3% of the total ca...

AI Technical Summary

Problems solved by technology

[0007] Currently using Panax notoginseng saponins and Tanshinone II A The interaction of sodium sulfonate and the compatibility of prescriptions to treat cardiovascular and cerebrovascular diseases have not been reported yet

Images